STOCK TITAN

Ensign Group Inc SEC Filings

ENSG Nasdaq

Welcome to our dedicated page for Ensign Group SEC filings (Ticker: ENSG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The Ensign Group, Inc. (Nasdaq: ENSG) files detailed reports with the U.S. Securities and Exchange Commission that describe its post-acute healthcare operations, skilled nursing and senior living services, and healthcare real estate activities. This SEC filings page brings together those documents, along with AI-powered tools that help explain the information they contain.

Ensign’s current reports on Form 8-K discuss topics such as quarterly financial results, the use of non-GAAP financial measures, and changes in board composition and executive roles. In these filings, the company explains how it calculates measures like Adjusted Net Income, Adjusted Earnings per Share, EBITDA, Adjusted EBITDA, Adjusted EBITDAR, Adjusted EBT and Funds from Operations (FFO) for its Standard Bearer real estate segment. These definitions help investors understand how Ensign evaluates performance in its skilled services and real estate businesses.

Through this page, users can access Ensign’s annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K as they are made available on EDGAR. AI-generated summaries highlight key points from lengthy filings, such as segment descriptions, the role of Standard Bearer Healthcare REIT, Inc., and the company’s approach to non-GAAP metrics. The platform also surfaces relevant information from Forms 3, 4 and 5 related to equity ownership and transactions by directors and officers, giving additional context on insider activity.

By combining real-time SEC updates with AI explanations, this ENSG filings page is intended to make Ensign’s regulatory disclosures more accessible to investors who want to understand its skilled nursing, senior living and healthcare real estate operations in greater depth.

Rhea-AI Summary

The Ensign Group, Inc. reported an insider stock transaction by its VP and Chief Legal Officer. On December 12, 2025, the officer exercised 2,500 employee stock options at an exercise price of $44.84 per share, acquiring the same number of common shares.

On the same date, the officer sold 1,000, 5,846 and 1,554 shares of common stock at weighted average sale prices of $174.1075, $175.516 and $176.207, respectively, leaving 32,779 common shares owned directly after the transactions and no remaining derivative securities. The activity was effected under a Rule 10b5-1 trading plan adopted on September 2, 2025, using options originally granted on May 28, 2020 that vest over five equal annual installments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

The Ensign Group, Inc. (ENSG) officer, the President and COO, reported an option exercise and share sale. On 11/20/2025, he exercised 3,690 employee stock options at an exercise price of $15.93 per share, receiving the same number of common shares. On the same date, he sold 3,690 common shares at a price of $180 per share. After these transactions, he beneficially owned 51,165 shares of Ensign common stock in direct ownership form.

The filing states that the transaction was carried out under a Rule 10b5-1 trading plan adopted on August 14, 2025. The options exercised were originally granted on August 31, 2016 and vested in five equal annual installments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Ensign Group, Inc. (ENSG) President and COO filed a Form 4 reporting multiple stock transactions in November 2025. On 11/17/2025, the officer made a gift of 4,229 shares of common stock and exercised stock options for 5,899 shares at $16.60 per share, then sold 5,899 shares at $177.30 per share. On 11/18/2025, the officer exercised options for 2,209 shares at $15.93 per share and sold 2,209 shares at $180.00 per share. After these transactions, the officer directly owned 51,165 shares of Ensign Group common stock and held 3,690 employee stock options. The filing notes that the transactions were carried out under a Rule 10b5-1 trading plan adopted on August 14, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Ensign Group, Inc. director reports small stock sale under 10b5-1 plan. A company director filed a Form 4 disclosing the sale of 1,000 shares of Ensign Group, Inc. common stock at a price of $178.57 per share on 11/18/2025. The transaction was coded as a sale and executed pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on May 7, 2025. After this trade, the director beneficially owns 24,126 shares of Ensign Group, Inc., all held directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Ensign Group (ENSG) reported insider transactions by CEO and director Barry R. Port. On 11/11/2025, a trust for the reporting person disposed of 4,820 shares as a gift. On 11/12/2025, he exercised options for 28,315 shares (at $15.80 and $45.34) and sold the same 28,315 shares in multiple trades under a Rule 10b5‑1 plan adopted August 12, 2025. Sale prices ranged from $179.4445 to $182.9538 based on weighted averages.

Following the sales, direct holdings were 56,481 shares. Indirect holdings by trust were 150,480 shares following the gift.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Ensign Group (ENSG) reported an insider transaction by its CFO and Director, Suzanne Snapper. On 11/07/2025, a Form 4 entry shows a code G transaction involving 2,675 shares of common stock at a stated price of $0. Following this transaction, the reporting person beneficially owned 266,529 shares directly.

In addition, the filing lists 59,015 shares held indirectly by the Eric and Suzanne Snapper Family Trust, for which Suzanne and Eric Snapper serve as trustees. The form was signed by Chad A. Keetch as power of attorney.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Ensign Group (ENSG) reported a director’s Form 4 showing new equity awards and a small tax-related sale. On 11/05/2025, the director acquired 1,600 shares of common stock at $0, and received an option to buy 4,000 shares at an exercise price of $189.93.

The option vests in five equal annual installments beginning November 5, 2026 and expires on November 5, 2035. On 11/07/2025, 73 shares were sold at $182.08 pursuant to a Rule 10b5-1 plan to cover taxes related to a prior restricted stock award. Following these transactions, the director beneficially owned 14,490 shares, held directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Ensign Group (ENSG) reported an insider transaction by a director. On 11/06/2025, the director sold 246 shares of common stock at $188.87 per share, reported with transaction code S. Following the sale, the director beneficially owns 8,879.149 shares, held directly. The filing notes the trade was effected under a Rule 10b5-1 trading plan adopted on July 31, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Ensign Group (ENSG) reported an insider transaction by its Chief Executive Officer and Director. On 11/06/2025, the reporting person used 549 shares of common stock to cover tax withholding from a previously granted restricted stock award, coded F, at a price of $182.91 per share.

Following the transaction, beneficial ownership stands at 56,481 shares held directly and 155,300 shares held indirectly by a trust. The restricted stock award was granted on November 6, 2024 and vests in five equal annual installments beginning November 6, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Ensign Group (ENSG) reported an insider transaction by its CFO and director. On 11/06/2025, 488 shares of common stock were withheld (Transaction Code F) at $182.91 per share to cover taxes upon vesting of a Restricted Stock Award granted on 11/06/2024 that vests in five equal annual installments beginning 11/06/2025.

Following the transaction, the reporting person beneficially owned 269,204 shares directly and 59,015 shares indirectly by trust.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Ensign Group (ENSG)?

The current stock price of Ensign Group (ENSG) is $183.54 as of January 15, 2026.

What is the market cap of Ensign Group (ENSG)?

The market cap of Ensign Group (ENSG) is approximately 10.3B.
Ensign Group Inc

Nasdaq:ENSG

ENSG Rankings

ENSG Stock Data

10.29B
55.92M
3.43%
94.65%
3.17%
Medical Care Facilities
Services-skilled Nursing Care Facilities
Link
United States
SAN JUAN CAPISTRANO